Stroke remains a significant cause of morbidity and mortality worldwide. Early recognition and swift intervention are crucial in mitigating the devastating consequences of this medical emergency. This article aims to provide healthcare professionals with a comprehensive guide to early stroke recognition and management.
Early stroke recognition is vital for prompt intervention. The BE FAST model is an effective tool for identifying potential stroke patients. B for Balance difficulties, E for Eyesight problems, F for Face drooping, A for Arm weakness, S for Speech difficulties, and T for Time to call emergency services. This model emphasizes the importance of swift action in the face of potential stroke symptoms.
Once a stroke is suspected, immediate management includes maintaining airway, breathing, and circulation, stabilizing vital signs, and initiating intravenous access. It is also crucial to obtain a rapid brain imaging study, preferably a non-contrast CT scan, to differentiate between ischemic and hemorrhagic stroke.
Acute ischemic stroke management may involve intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) if administered within 4.5 hours of symptom onset. Endovascular procedures like mechanical thrombectomy can be considered within 24 hours in certain patients. Hemorrhagic stroke management focuses on controlling blood pressure, reversing anticoagulation, and surgical intervention when indicated.
Stroke recognition and management require a systematic approach. Utilizing the BE FAST model can facilitate early identification of symptoms. Immediate stabilization, appropriate imaging, and timely intervention can significantly improve patient outcomes. As healthcare professionals, staying abreast of the latest guidelines and advancements in stroke care is paramount.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation